Proscillaridin activity in portal and peripheral venous blood after oral administration to man. 1977

K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell

The absorption of proscillaridin A was studied in four patients undergoing catheterization of the portal vein for diagnostic purposes. Proscillaridin 1.5 mg was given as a single oral dose and plasma glycoside activity was analyzed by the 86Rb-uptake inhibition technique. Proscillaridin appeared rapidly in the portal blood, peak activity being found after 15 min in three and after 30 min in one patient. In peripheral blood the peak activity occurred after approximately 35 min. Despite rapid passage across the gut wall, porto-peripheral differences in glycoside activity were small; they were zero after 4h. The mean amount absorbed as active porscillaridin during the first 4h after the dose was calculated to be only 7.1% of the given amount. Late porto-peripheral differences, probably due to enterohepatic recycling, appeared after 6h in three patients; The results suggest that proscillaridin undergoes first pass inactivation in the gut wall. Enterohepatic recirculation may contribute to the amounts of active glycoside that reach the systemic circulation.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011442 Proscillaridin A cardiotonic glycoside isolated from Scilla maritima var. alba (Squill). Desglucotransvaaline,Proscillaridin A,Scillarenin Rhamnoside,Caradrin,Digitalysat,Proscillaridine,Sandoscill,Scillase,Talusin,Rhamnoside, Scillarenin
D002018 Bufanolides Cyclopentanophenanthrenes with a 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. They are found in BUFONIDAE and often possess cardiotonic properties. Bufadienolides
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D005260 Female Females
D005542 Forearm Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. Antebrachium,Antebrachiums,Forearms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
November 1973, Gut,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
April 1967, Prensa medica argentina,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
January 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
October 1971, Diabetes,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
January 1973, Acta medica Scandinavica,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
January 1976, Endokrinologie,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
January 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
September 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
January 1974, European journal of clinical pharmacology,
K E Andersson, and B Bergdahl, and H Dencker, and G Wettrell
October 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!